$356.94−0.58%Close 16 Nov 2026 · Market value $67.23B
In its results release of 4 Nov 2026 (Q4 FY2026), Cencora, Inc. gave 2 forecasts in figures, among them EPS (adjusted) of $19.40 to $19.75 for FY2027.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q4 FY2026 results, 4 Nov 2026
| Measure | Period | Guidance | As stated |
|---|
| EPS · Adjusted | FY2027 | $19.40 to $19.75 | Fiscal 2027 Adjusted Diluted EPS Expected to be in the Range of $19.40 to $19.75, reflecting growth of 8 percent to 10 percent |
|---|
| EPS growth · Adjusted · Reaffirmed | FY2027 | +10% to +14% | The Company is reaffirming its long-term growth target that contemplates adjusted operating income growth of 7% to 10% and adjusted diluted EPS growth of 10% to 14%. |
|---|
Source: the company's earnings release.
Guidance against results above 1 · within 0 · below 0
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| EPS · Adjusted | FY2027 | $19.40 to $19.75 | Given once | — | To come |
|---|
| EPS growth · Adjusted | FY2027 | +10% to +14% | Given once | — | To come |
|---|
| EPS · Adjusted | FY2026 | $17.75 to $17.95 | Raised 3 times | — | To come |
|---|
| Free cash flow · Adjusted | FY2026 | $3.00B | Unchanged | — | To come |
|---|
| Capital expenditures | FY2026 | $900M | Unchanged | — | To come |
|---|
| Tax rate · Adjusted | FY2026 | 20% | Lowered once | — | To come |
|---|
| Revenue growth | FY2025 | About +9% | Raised once | +9.31% | Within the range |
|---|
| Capital expenditures | FY2025 | About $600M | Given once | $668M | Above the range |
|---|
COR in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.